GETTING A NEW LEASE OF LIFE WITH TRANSPLANTATION
Transplantation has been known to save lives. It brings hope and life for those suffering from end-stage organ failure, blood disorders and blood cancers. Continuous evolvement in research and pharmacology has now opened doors to transplantation which provides better and longer quality of life.
At Mount Elizabeth Hospital, we believe in providing our patients a multi-disciplinary approach to the clinical treatment and management of their conditions. Haematopoietic/bone marrow stem cell transplant, living donor kidney and liver transplants form the pillar of our Transplant & Cellular Therapy Programme; and they bring hope and provide therapies to patients in the world.
Living Donor Kidney Transplant (LDKT)
LDKT transforms the lives of people with end-stage kidney failure, freeing them from dialysis and enabling them to enjoy full and active lives. It is increasingly popular to carry out living donor kidney transplant before dialysis is initiated.Living donor transplantation offers many advantages, which include providing:
Better quality of life, as the transplant can be scheduled at the time when patient is at his/her healthier state
Better survival outcomes
Shorter waiting time, as compared to waitlisting for cadaveric donor
Our multi-disciplinary team of specialists offers a wide range of medical and surgical interventions to treat patients with kidney diseases including acute and chronic disease management, end-stage disease management and kidney transplantation. We adopt one of the latest medications and quality care to undertake complicated transplantations for blood group incompatible and crossmatch positive (sensitised group) patients. Mount Elizabeth is the first in offering such solutions to patients in Southeast Asia.
Living Donor Liver Transplant (LDLT)
LDLT has become an important and effective life-saving procedure, in particular for those with acute liver failure and hepatocellular carcinoma. The current waiting period for a cadaveric donor liver is much too long to benefit patients with these rapidly progressive diseases. Without LDLT, it is highly unlikely that patients will be transplanted before they develop fatal complications. Besides being an alternative source of donor livers, the other advantages of LDLT over cadaveric organ donation are:
It allows scheduling of the procedure. As such, the patient with decompensated liver function can be optimised prior to the operation.
Quality of the graft is better as it is retrieved from a healthy donor and the cold ischaemic time is much shorter.
Haematopoietic/Bone Marrow Stem Cell Transplant
provides comprehensive transplantation care from infants to adults with both malignant, benign, genetic and/or blood disorders. This treatment procedure is applicable alone or in combination with other treatments such as leukaemia, solid tumours, thalassaemia, sickle cell anaemia, metabolic diseases, immune deficiencies and autoimmune diseases.
Stem cell transplantation (bone marrow, peripheral blood or cord blood)
Autologous or allogeneic transplantation
Non-myeloablative allogeneic stem cell transplant (mini-transplant)
Enzyme replacement therapy
Targeted therapy treatment
Please contact Mount Elizabeth Patient Assistance Centre (MPAC) for more information.
Mount Elizabeth Patient Assistance Centre
24-Hours Hotline: +65 6250 0000